{"id":"NCT03331042","sponsor":"Sequential Medicine Ltd","briefTitle":"SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.","officialTitle":"A Randomized, Double-Blind, Single-Dose, 4-Way Crossover Study to Assess the Efficacy and Safety of SM-1 (50-mg Diphenhydramine, 5-mg Delayed-Release Zolpidem, and 0.5-mg Delayed-Release Lorazepam) Versus 2 Comparators (50-mg Diphenhydramine and 5-mg Delayed-Release Zolpidem; 50-mg Diphenhydramine and 0.5-mg Delayed-Release Lorazepam) and Placebo in a 5-Hour Phase Advance Model of Transient Insomnia.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-10-09","primaryCompletion":"2018-03-20","completion":"2018-03-22","firstPosted":"2017-11-06","resultsPosted":"2019-06-05","lastUpdate":"2019-06-05"},"enrollment":85,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Transient Insomnia"],"interventions":[{"type":"DRUG","name":"SM-1","otherNames":[]},{"type":"DRUG","name":"D+Z","otherNames":[]},{"type":"DRUG","name":"D+L","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Sequence 1","type":"EXPERIMENTAL"},{"label":"Sequence 2","type":"EXPERIMENTAL"},{"label":"Sequence 3","type":"EXPERIMENTAL"},{"label":"Sequence 4","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to investigate the effectiveness, safety and tolerability of a combination drug product (SM-1) containing diphenhydramine, zolpidem and lorazepam, in adult participants who sometimes have difficulty in falling asleep or staying asleep, but who do not have chronic insomnia. Participants will receive SM-1, or a combination of diphenhydramine and zolpidem, or a combination of diphenhydramine and lorazepam, or placebo during 4 one-night stays at a sleep center.","primaryOutcome":{"measure":"Total Sleep Time (TST)","timeFrame":"8 hours","effectByArm":[{"arm":"SM-1","deltaMin":401.82,"sd":68.074},{"arm":"Diphenhydramine Plus Zolpidem","deltaMin":404.83,"sd":47.252},{"arm":"Diphenhydramine Plus Lorazepam","deltaMin":397.28,"sd":56.982},{"arm":"Placebo","deltaMin":307.38,"sd":107.365}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":10,"exclusionCount":22},"locations":{"siteCount":2,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":84},"commonTop":["somnolence","asthenia","nightmare","abdominal pain","fatigue"]}}